Comparison of the clinical and electroencephalographical effects of molindone and trifluoperazine in acute schizophrenic patients.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001921:Brain / Q000187:drug effects; D002986:Clinical Trials as Topic; D004569:Electroencephalography; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D008972:Molindone / Q000494:pharmacology / Q000627:therapeutic use; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D014268:Trifluoperazine / Q000494:pharmacology / Q000627:therapeutic use*
D000928:Antidepressive Agents; D007211:Indoles; D010919:Placebos; D014268:Trifluoperazine; D008972:Molindone